NeoGenomics, Inc. recently announced that its PanTracer LBx liquid biopsy test has received Medicare coverage under the MolDX ...
NeoGenomics' PanTracer™ LBx test has received coverage from the Centers for Medicare & Medicaid Services’ Molecular ...
Medicare will now cover tests that screen for multiple types of cancer at once, under a new bipartisan law backed by Georgia ...
The program may soon provide broader coverage to improve retirees' health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results